MARIA CHRISTINA Christina lopes Araújo OLIVEIRA

Dr. MARIA CHRISTINA Christina lopes Araújo OLIVEIRA

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Laetitia KOPPELaetitia KOPPE
Laetitia KOPPE
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
DFDenis Fouque
Denis Fouque
Diet is a key component of care during chronic kidney disease (CKD). Nutritional interventions, and, specifically, a restricted protein diet has been under debate for decades. In order to reduce the risk of nutritional disorders in very-low protein diets (VLDP), supplementation by nitrogen-free ketoacid analogues (KAs) have been proposed. The aim of this review is to summarize the potential effects of this dietary therapy on renal function, uremic toxins levels, and nutritional and metabolic parameters and propose future directions. The purpose of this paper is also to select all experimental and randomized clinical studies (RCTs) that have compared VLDP + KA to normal diet or/and low protein diet (LPD). We reviewed the SCOPUS, WEB of SCIENCES, CENTRAL, and PUBMED databases from their inception to 1 January, 2019. Following duplicate removal and application of exclusion criteria, 23 RCTs and 12 experimental studies were included. LPD/VLPD + KAs appear nutritionally safe even if how muscle protein metabolism adapts to an LPD/VLPD + KAs is still largely unknown. VLPD + KAs seem to reduce uremic toxins production but the impact on intestinal microbiota remains unexplored. All studies observed a reduction of acidosis, phosphorus, and possibly sodium intake, while still providing adequate calcium intake. The impact of this diet on carbohydrate and bone parameters are only preliminary and need to be confirmed with RCTs. The Modification of Diet in Renal Disease study, the largest RCTs, failed to demonstrate a benefit in the primary outcome of the decline rate for the glomerular filtration rate. However, the design of this study was challenged and data were subsequently reanalyzed. However, when adherent patients were selected, with a rapid rate of progression and a long-term follow up, more recent meta-analysis and RCTs suggest that these diets can reduce the loss of the glomerular filtration rate in addition to the beneficial effects of renin-angiotensin-aldosterone system (RAAS) inhibitors. The current evidence suggests that KAs supplemented LPD diets should be included as part of the clinical recommendations for both the nutritional prevention and metabolic management of CKD. More research is needed to examine the effectiveness of KAs especially on uremic toxins. A reflection about the dose and composition of the KAs supplement, the cost-effective features, and their indication to reduce the frequency of dialysis needs to be completed.

1 January 2020 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
EOEduardo Oliveira
Eduardo Oliveira
HMHercilio Martelli-Junior
Hercilio Martelli-Junior
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
DMDaniella R. Barbosa Martelli
Daniella R. Barbosa Martelli
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
In this distressful scenario, there are some clues that the scientific output of the country is already declining (Bolaños-Villegas et al. 2020). In order to ascertain this issue further, we did a preliminary analysis associating the Brazilian scientific performance with the governmental financial support in the last 18 years. Figure 1 displays the devastating toll of the reduction of financial support on the scholarly output, mainly after 2011. From 2000 to 2009, there was a steady increase in the budget of MCTIC. Over this period, publications by Brazilian researchers in peer-reviewed journals had leapt from 14,237 to 50,415. The median annual growth rate of research papers was about 13%. This performance has led Brazil to jump from the 21th to the 13th position in the world ranking of scientific publications (Petherick 2010). On the other hand, from 2010 to 2017, in parallel with a systematic decrease in MCTIC budget, the median annual growth rate of research papers has plunged to only about 6%. Actually, since 2013, this figure is even worse, with a growth pace of only 4%. Consequently, Brazil´s position in the world ranking of scientific publications has already dropped to the 14th.

1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
EOEduardo Oliveira
Eduardo Oliveira
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
ECEnrico Antonio Colosimo
Enrico Antonio Colosimo
DMDaniella Reis Barbosa Martelli
Daniella Reis Barbosa Martelli
LSLudmila R. Silva
Ludmila R. Silva
HMHercilio Martelli-Junior
Hercilio Martelli-Junior
Based on an extensive analysis of public databases, we provide an overview of the global scientific output and describe the dynamics of the profound changes in the scientific enterprise during the last decades. The analysis included the scientific production of 53 countries over the 1996-2018 period. During this period, the production of articles per year has tripled. There was a strong correlation between the growth of the global gross domestic product and the increase in the number of articles (R2 = 0.973, P<0.001). Six countries showed a robust increment of their scientific production and are currently among the top 20 in the ranking of world scientific production (China, India, South Korea, Brazil, Turkey, and Iran). The mean annual growth rate was about 12.7% for these six countries. The share of the global scientific production of these countries increased from 7% in 1996 to 27.8% in 2018. Conversely, the participation of the 10 most traditional countries has dropped from 73% to 45% during the same period. In conclusion, we believe that our findings may contribute to further studies aiming to evaluate the impact and changes of the scientific endeavor over the next years in light of the forthcoming new world framework.

1 January 2012 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
KCKeyla C. C. Mendes Sampaio Cunha
Keyla C. C. Mendes Sampaio Cunha
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
AGAna Cecília Silva Gomes
Ana Cecília Silva Gomes
LCLucia Porto Fonseca de Castro
Lucia Porto Fonseca de Castro
MVMarcos Borato Viana
Marcos Borato Viana
Burkitt's lymphoma is the most common subtype of non-Hodgkin lymphoma in children. The aim of this study was to characterize the clinical course and prognostic factors of children and adolescents with Burkitt's lymphoma treated in the Hematology Unit of Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG). A retrospective cohort study was made of 50 consecutive cases of children and adolescents aged 16 years or less with Burkitt's lymphoma admitted between January 1981 and December 2007. Prognostic factors associated with death were evaluated using the Kaplan-Meier method and compared by the two-tailed log-rank test. The median age at diagnosis was 4.7 years. Most patients had abdominal tumors (66.7%) and advanced disease (68.9%) at diagnosis. Thirty-eight patients (84.4%) achieved complete clinical remission and 33 (73.3%) were alive at the first remission. Twelve children (26.7%) died. The median follow-up was 35 months with the probability of overall survival being 73% (89.2% and 35.7% for patients with uric acid < 7 mg/dL and ≥ 7.0 mg/dL, respectively - p-value < 0.001). Uric acid was the only significant prognostic factor at diagnosis. Our findings confirm the favorable prognosis of children with Burkitt's lymphoma even when treated with intermediate doses of methotrexate (500 mg/m2). Survival was significantly lower for individuals with concentrations of uric acid > 7 mg/dL.

1 May 2019 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
DMDaniella Reis Barbosa Martelli
Daniella Reis Barbosa Martelli
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
SPSergio Veloso Pinheiro
Sergio Veloso Pinheiro
MSMaria Luiza Santos
Maria Luiza Santos
VDVeronica Dias
Veronica Dias
EOEduardo Oliveira
Eduardo Oliveira
SUMMARY BACKGROUND. This study aimed to evaluate the scientific production of researchers in the field of Medicine who receive a productivity grant from the CNPq. METHODS: The curriculum Lattes of 542 researchers with active grants from 2012 to 2014 were included in the analysis. Grants categories/levels were stratified into three groups according to the CNPq database (1A-B, 1C-D, and 2). RESULTS. There was a predominance of grants in category 2. During their academic career, Medicine researchers published 76512 articles, with a median of 119 articles per researcher (IQ, interquartile range, 77 to 174). Among the 76512 articles, 36584 (47.8%) were indexed in the Web of Science (WoS database). Researchers in Medicine were cited 643159 times in the WoS database, with a median of 754 citations (IQ, 356 to 1447). There were significant differences among the categories of grants concerning the number of citations in WoS (P <0.001). There was a significant difference in the number of times researchers were cited according to the specialty included in Medicine area. (P < 0.001). CONCLUSION. Strategies to improve the scientific output qualitatively possibly can be enhanced by the knowledge of the profile of researchers in the field of Medicine.

1 October 2015 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
KSKeyla Christy Sampaio
Keyla Christy Sampaio
AOAline Carneiro Oliveira
Aline Carneiro Oliveira
ASAieska Dantas Santos
Aieska Dantas Santos
LCLúcia Porto Castro
Lúcia Porto Castro
MVMarcos Borato Viana
Marcos Borato Viana
Summary Introduction: lymphoblastic lymphoma (LBL) is the second most common subtype of non-Hodgkin lymphoma in children. The aim of this study was to characterize the clinical course of children and adolescents with LBL treated at a tertiary center. Methods: this is a retrospective cohort study of 27 patients aged 16 years or younger with LBL admitted between January 1981 and December 2013. Patients were treated according to the therapy protocol used for acute lymphoblastic leucemia. Diagnosis was based on biopsy of tumor and/or cytological examination of pleural effusions. The overall survival was analyzed using the Kaplan-Meier method. Results: the median age at diagnosis was 11.6 years (interquartile range, 4.6- 13.8). LBL had T-cell origin in 16 patients (59%). The most common primary manifestation in T-cell LBL was mediastinal involvement, in 9 patients (56%). Intra-abdominal tumor was the major site of involvement in patients with precursor B-LBL. Most patients had advanced disease (18 patients – 67%) at diagnosis. Twenty-four patients (89%) achieved complete clinical remission. After a median follow-up of 43 months (interquartile range, 6.4-95), 22 patients (81%) were alive in first complete remission. Five children (18.5%) died, three of them soon after admission and two after relapsing. The probability of survival at five years for 20 patients with de novo LBL was 78% (SD 9.4). Conclusion: our findings confirm the favorable prognosis of children with LBL with an intensive chemotherapy regimen derived from ALL therapy.